Flex-201: A multicenter, randomized, blinded study to evaluate the efficacy and tolerability of FLX-787 in MS

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2017
This article has no abstract
Epistemonikos ID: 12e58d90da83d28b38e06aa2bba8fac938653fb5
First added on: Apr 29, 2026